Results 151 to 160 of about 1,396 (170)

Serum Amino Acid Profiling in Patients With Alkaptonuria Before and After Treatment With Nitisinone [PDF]

open access: yesJIMD Reports, 2018
Background: Alkaptonuria (AKU) is a rare inherited disorder of the tyrosine metabolic pathway. Our group is evaluating the use of the homogentisic acid-lowering agent nitisinone in patients with AKU.
Andrew Davison   +2 more
exaly   +2 more sources

[New drugs; nitisinone].

Nederlands tijdschrift voor geneeskunde, 2007
Nitisinone is an inhibitor of 4-hydroxyphenyl-pyruvate dioxygenase (4HPPD). Its rare area of use is hereditary tyrosinaemia, a life-threatening disease in which the last step in the catabolism of tyrosine cannot be taken due to the absence of an enzyme.
A F, Cohen, H, van Bronswijk
openaire   +1 more source

History of Nitisinone (NTBC)

2015
The clinical use of nitisinone, also known as NTBC, has a fascinating history in the context of modern medical practice. This is a remarkable account of how a weed killer has become the mainstay in the treatment of hereditary tyrosinaemia type 1, a lethal inherited metabolic disorder.
openaire   +1 more source

Nitisinone

Reactions Weekly, 2023
openaire   +1 more source

Nitisinone

Reactions Weekly, 2013
openaire   +2 more sources

Nitisinone

Reactions Weekly, 2018
openaire   +2 more sources

Liver transplantation for tyrosinemia in the nitisinone era

2019
[No abstract available]
Karaca, C.   +5 more
openaire   +1 more source

Experience of Nitisinone for the Pharmacological Treatment of Hereditary Tyrosinaemia Type 1

Expert Opinion on Pharmacotherapy, 2008
Ulrich Baumann, Saikat Santra
exaly  

Home - About - Disclaimer - Privacy